Fibrolamellar Carcinoma: What Is New and Why It Matters

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Fibrolamellar carcinoma is distinctive at clinical and histologic levels. A novel DNAJB1-PRKACA fusion gene characterizes almost all cases, distinguishes it from other hepatocellular neoplasms, and drives the pathogenesis of this unique tumor. A subset of cases of fibrolamellar carcinoma is associated with alternate mechanisms of protein kinase A activation. This review article discusses common and unusual histologic features of fibrolamellar carcinoma, its differential diagnoses, and how to make the diagnosis while avoiding key pitfalls. The impact of the discovery of the fusion gene on the understanding of the tumor and the prognosis of fibrolamellar carcinoma are also discussed.

Original languageEnglish (US)
Pages (from-to)377-387
Number of pages11
JournalSurgical Pathology Clinics
Issue number2
StatePublished - Jun 1 2018


  • Carney complex
  • Central scar
  • Fibrolamellar carcinoma
  • Fibrolamellar hepatocellular carcinoma
  • Hepatocellular carcinoma
  • Pale bodies
  • Protein kinase A

ASJC Scopus subject areas

  • Surgery
  • Pathology and Forensic Medicine


Dive into the research topics of 'Fibrolamellar Carcinoma: What Is New and Why It Matters'. Together they form a unique fingerprint.

Cite this